Details van artikel 164 van 210 gevonden artikelen
5.25 Safety and Tolerability of Oral Fludarabine, with or without Oral Cyclophosphamide and Intravenous Rituximab Therapy, in Previously Untreated Patients with Chronic Lymphocytic Leukaemia Aged 65 Years or Older: Second Interim Analysis from the Australasian Leukaemia and Lymphoma Group and CLL Australian Research Consortium CLL5 Study
Titel:
5.25 Safety and Tolerability of Oral Fludarabine, with or without Oral Cyclophosphamide and Intravenous Rituximab Therapy, in Previously Untreated Patients with Chronic Lymphocytic Leukaemia Aged 65 Years or Older: Second Interim Analysis from the Australasian Leukaemia and Lymphoma Group and CLL Australian Research Consortium CLL5 Study
Auteur:
Mulligan, Stephen P. Gill, Devinder Turner, Paul Renwick, William Harrup, Rosemary Latimer, Maya Berkahn, Leanne Simpson, David Sulda, Melanie Best, Giles Kuss, Bryone Cull, Gavin
Verschenen in:
Clinical lymphoma myeloma and leukemia
Paginering:
Jaargang 11 (2011) nr. S2 pagina's 2 p.
Jaar:
2011
Inhoud:
Uitgever:
Elsevier Inc.
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 164 van 210 gevonden artikelen